Organon and CAF, Development Bank of Latin America Team Up to Improve Financing in Women’s Health
The collaboration will use results-based financing to achieve its goals.
Organon and CAF, Development Bank of Latin America, announced that they are collaborating to increase sustainable financing in women’s health. The two organizations will design and implement sustainable programs for women in Latin America and the Caribbean. These programs will improve equity, health, and autonomy for the women involved.
In a press release, the two organizations announced that they had signed a memorandum of understanding with the United Nations Sustainable Development Goals.
These programs will aim to provide sustainable financing to women in the targeted areas.
“At Organon, we believe that results-based financing can drive collective action to progressing women’s health goals,” Kevin Ali, Organon CEO, said in the press release. “We are proud of our first-of-its-kind collaboration with CAF, built specifically to positively affect the health of women–and ultimately a country’s economy and development.”
Organon describes itself as a global healthcare company focused on improving women’s health.
“This agreement with Organon will help us to join forces in order to break with the structural barriers that keep limiting the access of women to health, financial and non-financial services,” Sergio Diaz-Granados, Executive President of CAF said in the press release.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
